Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Pathways to new therapeutic agents for human coronaviruses

Key clinical point: Previously available antivirals and new therapeutics show promise in treating human coronaviruses.

Major finding: Small-molecule, antihuman CoV therapies targeting different stages of the CoV life cycle are being developed.

Study details: A review of current research into anticoronavirus therapeutics.

Disclosures: The authors reported that they had no financial conflicts of interest.

Citation:

Pillaiyar T et al. Drug Discov Today. 2020 Jan 30. doi: 10.1016/j.drudis.2020.01.015.